Literature DB >> 6746909

Effects of acute changes of bile acid pool composition on biliary lipid secretion.

N Carulli, P Loria, M Bertolotti, M Ponz de Leon, D Menozzi, G Medici, I Piccagli.   

Abstract

To elucidate the mechanism responsible for the bile acid-induced changes of biliary lipid secretion, we evaluated bile flow and biliary output of bile acids, cholesterol, phospholipids, and alkaline phosphatase activity in seven cholecystectomized subjects with a balloon occludable T-tube during two experimental periods: (a) depletion of the endogenous bile acid pool and (b) replacement of the pool by means of duodenal infusion with individual bile acids, such as deoxycholic (DCA), chenodeoxycholic (CDCA), cholic (CA), and ursodeoxycholic (UDCA) acids. Bile flow, cholesterol, and phospholipid output were linearly related to bile acid secretion in all experimental periods. During the replacement periods, the amount of cholesterol and phospholipids coupled to bile acids was significantly different (at 1% level at least) for each individual bile acid secreted; it was the highest during DCA secretion (slope value: 0.209 for cholesterol and 0.434 for phospholipids) followed, in the order, by CDCA (0.078 and 1.794), CA (0.044 and 0.127), and UDCA (0.030 and 0.122). The phospholipid to cholesterol ratio was higher during secretion of CA and UDCA as compared with DCA and CDCA. The secretion of CA seemed to stimulate a greater bile flow than the other bile acids did. The infusion of all bile acids, except UDCA, induced an increase of biliary alkaline phosphatase activity as compared with the values of the depletion period. The mean highest increase (13-fold the pretreatment value) was observed during DCA secretion followed by CDCA (fivefold) and CA (1.5-fold). These results would suggest that the physical chemical properties, namely the lipid-solubilizing capacity, of bile acids could directly contribute to the regulation of biliary lipid secretion. The observed changes in biliary alkaline phosphatase activity lend support to the view that bile acid-induced lipid secretion may be, at least in part, contributed by membrane solubilization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6746909      PMCID: PMC370514          DOI: 10.1172/JCI111459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Influence of deoxycholic acid on biliary lipids in man.

Authors:  J Ahlberg; B Angelin; K Einarsson; K Hellstrom; B Leijd
Journal:  Clin Sci Mol Med       Date:  1977-09

2.  Kinetic analysis of biliary lipid excretion in man and dog.

Authors:  C I Wagner; B W Trotman; R D Soloway
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

3.  Effect of beta-sitosterol alone or in combination with chenic acid on cholesterol saturation of bile and cholesterol absorption in gallstone patients.

Authors:  T N Tangedahl; J L Thistle; A F Hofmann; J W Matseshe
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

4.  Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.

Authors:  M J Coyne; G G Bonorris; L I Goldstein; L J Schoenfield
Journal:  J Lab Clin Med       Date:  1976-02

5.  Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.

Authors:  I Makino; S Nakagawa
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

6.  Effects of different bile salts upon the composition and morphology of a liver plasma membrane preparation. Deoxycholate is more membrane damaging than cholate and its conjugates.

Authors:  O S Vyvoda; R Coleman; G Holdsworth
Journal:  Biochim Biophys Acta       Date:  1977-02-14

7.  The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.

Authors:  M Ponz de Leon; N Carulli; P Loria; R Iori; F Zironi
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

8.  Critical tables for calculating the cholesterol saturation of native bile.

Authors:  M C Carey
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

9.  Influence of cholic and chenodeoxycholic acid on biliary cholesterol secretion in man.

Authors:  L Lindblad; K Lundholm; T Scherstén
Journal:  Eur J Clin Invest       Date:  1977-10       Impact factor: 4.686

10.  Bile lipid composition and bile acid pool size in diabetes.

Authors:  M P de Leon; R Ferenderes; N Carulli
Journal:  Am J Dig Dis       Date:  1978-08
View more
  17 in total

1.  Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Authors:  G Mazzella; P Fusaroli; A Pezzoli; F Azzaroli; C Mazzeo; L Zambonin; P Simoni; D Festi; E Roda
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Medical aspects of gallstones--1985: sixty years on.

Authors:  R H Dowling; D Gleeson
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

Review 3.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.

Authors:  S Ginanni Corradini; G Yamashita; H Nuutinen; A Chernosky; C Williams; L Hays; M L Shiffman; R M Walsh; J Svanvik; P Della Guardia; L Capocaccia; R T Holzbach
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.

Authors:  Meimin Xie; Vijay R Kotecha; Jon David P Andrade; James G Fox; Martin C Carey
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

6.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  Disorders of bile acid metabolism in cholesterol gallstone disease.

Authors:  F Berr; E Pratschke; S Fischer; G Paumgartner
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.

Authors:  H Noshiro; K Chijiiwa; I Makino; K Nakano; I Hirota
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis.

Authors:  P Di Donato; F Carubbi; M Ponz de Leon; N Carulli
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

Review 10.  Pharmacological treatment of gallstones. Practical guidelines.

Authors:  A Lanzini; T C Northfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.